In addition, previous studies have shown that BACE2 is upregulated in primary breast cancer and colorectal cancer as well as in colorectal adenomas (Shao et al., 2018; Tsuji et al., 2004), thus indicating the key role for BACE2 in malignant tumour progression. This evidence concerns the gene BACE2 and colorectal cancer.